Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis : A Randomized Controlled Trial.
Saved in:
| Title: | Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis : A Randomized Controlled Trial. |
|---|---|
| Authors: | Terrier B; National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), and Université Paris Cité, Paris, France (B.T., L.G., X.P.)., Pugnet G; Department of Internal Medicine and Clinical Immunology, CHU Toulouse Rangueil, Toulouse, France (G.P., D.C.)., de Moreuil C; Department of Internal Medicine, CHU Brest, Brest, France (C.deM.)., Bonnotte B; Department of Internal Medicine, University Hospital Dijon-Bourgogne, and EFS, INSERM U1098, UMR RIGHT, Bourgogne Franche-Comté University, Dijon, France (B.B.)., Benhamou Y; Department of Internal Medicine, CHU Rouen, Rouen, France (Y.B.)., Chauveau D; Department of Internal Medicine and Clinical Immunology, CHU Toulouse Rangueil, Toulouse, France (G.P., D.C.)., Besse MC; Department of Internal Medicine, CHU Tours, Tours, France (M.-C.B.)., Duffau P; Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Saint-André, CHU Bordeaux, and Univ-Bordeaux, CNRS UMR5164 Immunoconcept, Bordeaux, France (P.D.)., Limal N; Department of Internal Medicine, Hôpital Henri Mondor, AP-HP, Université Paris Est Créteil, Créteil, France (N.L.)., Néel A; Department of Internal Medicine, Nantes University Hospital, and Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, Nantes, France (A.N.)., Urbanski G; Department of Internal Medicine and Clinical Immunology, University Hospital, Angers, France (G.U.)., Jourde-Chiche N; AP-HM Centre de Néphrologie et Transplantation Rénale, CHU Conception, and Aix-Marseille Université, C2VN, INSERM, INRAE, Marseille, France (N.J.-C.)., Martin-Silva N; Department of Clinical Immunology and Internal Medicine, CHU Caen Normandie, Caen, France (N.M.-S.)., Campagne J; Department of Internal Medicine, Hôpital Robert Schuman, Vantoux, France (J.Campagne)., Mekinian A; Department of Internal Medicine, Saint Antoine Hospital, AP-HP, Sorbonne Université, Paris, France (A.M.)., Schleinitz N; Department of Internal Medicine, Hôpital Timone, AP-HM, Aix-Marseille University, Marseille, France (N.S.)., Ackermann F; Department of Internal Medicine, Hôpital Foch, Suresnes, France (F.A.)., Fauchais AL; Department of Internal Medicine, CHU Dupuytren, Limoges, France (A.-L.F.)., Froissart A; Department of Internal Medicine, CHI de Créteil, Créteil, France (A.F.)., Le Gallou T; Department of Internal Medicine, CHU de Rennes, Rennes, France (T.L.G.)., Uzunhan Y; Department of Pulmonology, CHU Avicenne, AP-HP, Bobigny, France (Y.U.)., Viallard JF; Department of Internal Medicine, Bordeaux University Hospital, Pessac, France (J.F.V.)., Bérezné A; Department of Internal Medicine, Centre Hospitalier Annecy Genevois, Annecy, France (A.B.)., Chiche L; Department of Internal Medicine, Hôpital Européen, Marseille, France (L.C.)., Taillé C; Department of Pulmonology, CHU Bichat, AP-HP, Paris, France (C.T.)., Direz G; Rheumatology Department, Le Mans General Hospital, Le Mans, France (G.D.)., Durel CA; Department of Internal Medicine, Hôpital Saint Joseph Saint Luc, Lyon, France (C.-A.D.)., Godmer P; Department of Hematology and Clinical Immunology, Groupe Hospitalier Bretagne Atlantique, Vannes, France (P.G.)., Trad S; Department of Internal Medicine, Hôpital Ambroise-Paré, AP-HP, Boulogne-Billancourt, France (S.T.)., Lambert M; Department of Internal Medicine, CHRU Lille, Lille, France (M.L.)., de Menthon M; Department of Internal Medicine and Clinical Immunology, CHU Bicêtre, AP-HP, Le Kremlin-Bicêtre, France (M.deM.)., Quéméneur T; Department of Internal Medicine, CH Valenciennes, Valenciennes, France (T.Q.)., Cadranel J; Department of Pulmonology, CHU Tenon, AP-HP, Paris, France (J.Cadranel)., Charles P; Department of Internal Medicine, Institut Mutualiste Montsouris, Paris, France (P.C.)., Dossier A; Department of Internal Medicine, CHU Bichat, AP-HP, Paris, France (A.D., L.J., H.A.)., Jilet L; Department of Internal Medicine, CHU Bichat, AP-HP, Paris, France (A.D., L.J., H.A.)., Guillevin L; National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), and Université Paris Cité, Paris, France (B.T., L.G., X.P.)., Abdoul H; Department of Internal Medicine, CHU Bichat, AP-HP, Paris, France (A.D., L.J., H.A.)., Puéchal X; National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), and Université Paris Cité, Paris, France (B.T., L.G., X.P.). |
| Corporate Authors: | French Vasculitis Study Group |
| Source: | Annals of internal medicine [Ann Intern Med] 2025 Sep; Vol. 178 (9), pp. 1249-1257. Date of Electronic Publication: 2025 Jul 29. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Comparative Study; Equivalence Trial |
| Journal Info: | Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann Intern Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1539-3704 |
|---|---|
| DOI: | 10.7326/ANNALS-24-03947 |
